{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:47Z","timestamp":1786980107563,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07552-9","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T16:22:56Z","timestamp":1718814176000},"page":"631-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effects of various therapies on vulvovaginal atrophy and quality of life in gynecological cancer patients: a systematic review"],"prefix":"10.1007","volume":"310","author":[{"given":"Alu\u00edsio Gon\u00e7alves","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Molinar Mauad","family":"Cintra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene Ant\u00f4nia","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Penna","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Rodrigues","family":"do Carmo Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-7788","authenticated-orcid":false,"given":"Juliana Reis","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"7552_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","volume":"215","author":"J Gandhi","year":"2016","unstructured":"Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA (2016) Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 215:704\u2013711. https:\/\/doi.org\/10.1016\/j.ajog.2016.07.045","journal-title":"Am J Obstet Gynecol."},{"key":"7552_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11764-016-0585-9","volume":"11","author":"J Carter","year":"2017","unstructured":"Carter J, Stabile C, Seidel B, Baser RE, Goldfarb S, Goldfrank DJ (2017) Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors. J Cancer Surviv 11:274\u2013283. https:\/\/doi.org\/10.1007\/s11764-016-0585-9","journal-title":"J Cancer Surviv"},{"key":"7552_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/GME.0000000000000926","volume":"24","author":"ED Cook","year":"2017","unstructured":"Cook ED, Iglehart EI, Baum G, Schover LL, Newman LL (2017) Missing documentation in breast cancer survivors: genitourinary syndrome of menopause. Menopause 24:1360\u20131364. https:\/\/doi.org\/10.1097\/GME.0000000000000926","journal-title":"Menopause"},{"key":"7552_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/COC.0b013e318248d89d","volume":"37","author":"M DeSimone","year":"2014","unstructured":"DeSimone M, Spriggs E, Gass JS, Carson SA, Krychman ML, Dizon DS (2014) Sexual dysfunction in female cancer survivors. Am J Clin Oncol. 37:101\u2013106. https:\/\/doi.org\/10.1097\/COC.0b013e318248d89d","journal-title":"Am J Clin Oncol."},{"key":"7552_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1586\/EOG.11.3","volume":"6","author":"R Burich","year":"2014","unstructured":"Burich R, Degregorio M (2014) Current treatment options for vulvovaginal atrophy. Expert Rev Obstet Gynecol 6:141\u2013151. https:\/\/doi.org\/10.1586\/EOG.11.3","journal-title":"Expert Rev Obstet Gynecol"},{"key":"7552_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/GME.0000000000000549","volume":"23","author":"EA Erekson","year":"2016","unstructured":"Erekson EA, Li FY, Martin DK, Fried TR (2016) Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause 23:368\u2013375. https:\/\/doi.org\/10.1097\/GME.0000000000000549","journal-title":"Menopause"},{"key":"7552_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/13697137.2013.871696","volume":"17","author":"RE Nappi","year":"2014","unstructured":"Nappi RE, Palacios S (2014) Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 17:3\u20139. https:\/\/doi.org\/10.3109\/13697137.2013.871696","journal-title":"Climacteric"},{"key":"7552_CR8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","volume":"124","author":"DD Rahn","year":"2014","unstructured":"Rahn DD, Carberry C, Sanses TV, Mamik MM, Ward RM, Meriwether KV, Olivera CK, Abed H, Balk EM, Murphy M, Society of Gynecologic Surgeons Systematic Review Group (2014) Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol 124:1147\u20131156. https:\/\/doi.org\/10.1097\/AOG.0000000000000526","journal-title":"Obstet Gynecol"},{"key":"7552_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1634\/theoncologist.11-2-96","volume":"11","author":"MT Knobf","year":"2006","unstructured":"Knobf MT (2006) The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. Oncologist 11:96\u2013110. https:\/\/doi.org\/10.1634\/theoncologist.11-2-96","journal-title":"Oncologist"},{"issue":"2","key":"7552_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13697137.2017.1421921","volume":"21","author":"E Moral","year":"2018","unstructured":"Moral E, Delgado JL, Carmona F, Caballero B, Guill\u00e1n C, Gonz\u00e1lez PM, Su\u00e1rez-Almarza J, Velasco-Ortega S, Nieto C (2018) Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric 21(2):167\u2013173. https:\/\/doi.org\/10.1080\/13697137.2017.1421921","journal-title":"Climacteric"},{"key":"7552_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3978\/j.issn.2223-4683.2015.04.06","volume":"4","author":"PT Jensen","year":"2015","unstructured":"Jensen PT, Froeding LP (2015) Pelvic radiotherapy and sexual function in women. Transl Androl Urol 4:186\u2013205. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2015.04.06","journal-title":"Transl Androl Urol"},{"key":"7552_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ygyno.2017.06.013","volume":"146","author":"MG Del Carmen","year":"2017","unstructured":"Del Carmen MG, Rice LW (2017) Management of menopausal symptoms in women with gynecologic cancers. Gynecol Oncol. 146:427\u2013435. https:\/\/doi.org\/10.1016\/j.ygyno.2017.06.013","journal-title":"Gynecol Oncol."},{"key":"7552_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00192-017-3291-x","volume":"28","author":"S Kapoor","year":"2017","unstructured":"Kapoor S, Sivanesan K, Robertson JA, Veerasingham M, Kapoor V (2017) Sacrospinous hysteropexy: review and meta-analysis of outcomes. Int Urogynecol J 28:1285\u20131294. https:\/\/doi.org\/10.1007\/s00192-017-3291-x","journal-title":"Int Urogynecol J"},{"key":"7552_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.maturitas.2014.02.015","volume":"78","author":"D Portman","year":"2014","unstructured":"Portman D, Palacios S, Nappi RE, Mueck AO (2014) Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Maturitas. 78:91\u201398. https:\/\/doi.org\/10.1016\/j.maturitas.2014.02.015","journal-title":"Maturitas."},{"key":"7552_CR15","doi-asserted-by":"publisher","unstructured":"Salvatore S, Athanasiou S, Candiani M (2015) The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Curr Opin Obstet Gynecol 27:504\u2013508. https:\/\/doi.org\/10.1097\/GCO.0000000000000230. Erratum in: Curr Opin Obstet Gynecol 2017, 29:282","DOI":"10.1097\/GCO.0000000000000230"},{"key":"7552_CR16","doi-asserted-by":"publisher","first-page":"7513610","DOI":"10.1155\/2017\/7513610","volume":"2017","author":"N De Rosa","year":"2017","unstructured":"De Rosa N, Lavitola G, Giampaolino P, Morra I, Nappi C, Bifulco G (2017) Impact of Ospemifene on quality of life and sexual function in young survivors of cervical cancer: a prospective study. Biomed Res Int 2017:7513610. https:\/\/doi.org\/10.1155\/2017\/7513610","journal-title":"Biomed Res Int"},{"key":"7552_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ygyno.2020.01.035","volume":"157","author":"AK Sinno","year":"2020","unstructured":"Sinno AK, Pinkerton J, Febbraro T, Jones N, Khanna N, Temkin S, Iglesias D, Pothuri B (2020) Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: a Society of Gynecologic Oncology (SGO) clinical practice statement: this practice statement has been endorsed by The North American Menopause Society. Gynecol Oncol 157:303\u2013306. https:\/\/doi.org\/10.1016\/j.ygyno.2020.01.035","journal-title":"Gynecol Oncol"},{"key":"7552_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","volume":"17","author":"N Biglia","year":"2017","unstructured":"Biglia N, Bounous VE, D\u2019Alonzo M, Ottino L, Tuninetti V, Robba E, Perrone T (2017) Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists. Clin Breast Cancer 17:611\u2013617. https:\/\/doi.org\/10.1016\/j.clbc.2017.05.008","journal-title":"Clin Breast Cancer"},{"key":"7552_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5123\/S1679-49742015000200017","volume":"24","author":"TF Galvao","year":"2015","unstructured":"Galvao TF, Pansani TSA, Harrad D (2015) Principais itens para relatar Revisoes sistem\u00e1ticas e Meta-an\u00e1lises: a recomendacao Prisma. Epidemiologia e Servicos de Sa\u00fade 24:335\u2013342. https:\/\/doi.org\/10.5123\/S1679-49742015000200017","journal-title":"Epidemiologia e Servicos de Sa\u00fade"},{"key":"7552_CR20","doi-asserted-by":"crossref","unstructured":"McGowan JM, Sampson DM, Salzwedel E, Cogo V (2016) Foerster, and C. Lefebvre, \u201cPRESS Peer Review of ElectronicSearch Strategies: 2015 Guideline Statement,\u201d Journal of Clin-ical Epidemiology, vol. 75, pp. 40\u201346 (PDF) Neuroprotective Treatments for Digestive Forms of Chagas Disease in Experimental Models: a Systematic Review. Available from: https:\/\/www.researchgate.net\/publication\/363856599_Neuroprotective_Treatments_for_Digestive_Forms_of_Chagas_Disease_in_Experimental_Models_A_Systematic_Review [accessed Nov 23 2023]","DOI":"10.1016\/j.jclinepi.2016.01.021"},{"key":"7552_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/ijgc-2019-001028","volume":"30","author":"R Angioli","year":"2020","unstructured":"Angioli R, Stefano S, Filippini M, Pieralli A, Montera R, Plotti F, Gatti A, Bartolone M, Luvero D (2020) Effectiveness of CO2 laser on urogenital syndrome in women with a previous gynecological neoplasia: a multicentric study. Int J Gynecol Cancer 30:590\u2013595. https:\/\/doi.org\/10.1136\/ijgc-2019-001028","journal-title":"Int J Gynecol Cancer"},{"key":"7552_CR22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/cancers12061639","volume":"12","author":"AM Perrone","year":"2020","unstructured":"Perrone AM, Tesei M, Ferioli M, De Terlizzi F, Della Gatta AN, Boussedra S, Dondi G, Galuppi A, Morganti AG, De Iaco P (2020) Results of a phase I\u2013II study on laser therapy for vaginal side effects after radiotherapy for cancer of uterine cervix or endometrium. Cancers (Basel) 12:1639. https:\/\/doi.org\/10.3390\/cancers12061639","journal-title":"Cancers (Basel)"},{"key":"7552_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.maturitas.2020.10.018","volume":"144","author":"AM Quick","year":"2020","unstructured":"Quick AM, Dockter T, Le-Rademacher J, Salani R, Hudson C, Hundley A, Terstriep S, Streicher L, Faubion S, Loprinzi CL, Coleman JS, Wang KC, Lustberg M (2020) Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors. Maturitas 144:37\u201344. https:\/\/doi.org\/10.1016\/j.maturitas.2020.10.018","journal-title":"Maturitas"},{"key":"7552_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/medicina55100615","volume":"55","author":"S Alvisi","year":"2019","unstructured":"Alvisi S, Gava G, Orsili I, Giacomelli G, Baldassarre M, Seracchioli R, Meriggiola MC (2019) Vaginal Health in Menopausal Women. Medicina (Kaunas) 55:615. https:\/\/doi.org\/10.3390\/medicina55100615","journal-title":"Medicina (Kaunas)"},{"key":"7552_CR25","doi-asserted-by":"publisher","first-page":"CD007291","DOI":"10.1002\/14651858.CD007291.pub3","volume":"2014","author":"T Miles","year":"2014","unstructured":"Miles T, Johnson N (2014) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev 2014:CD007291. https:\/\/doi.org\/10.1002\/14651858.CD007291.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"7552_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJWH.S41897","volume":"5","author":"MJ Minkin","year":"2013","unstructured":"Minkin MJ, Maamari R, Reiter S (2013) Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy. Int J Womens Health 5:133\u2013139. https:\/\/doi.org\/10.2147\/IJWH.S41897","journal-title":"Int J Womens Health"},{"key":"7552_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/GME.0000000000001416","volume":"27","author":"MFR Paraiso","year":"2020","unstructured":"Paraiso MFR, Ferrando CA, Sokol ER, Rardin CR, Matthews CA, Karram MM, Iglesia CB (2020) A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET Trial. Menopause. 27:50\u201356. https:\/\/doi.org\/10.1097\/GME.0000000000001416","journal-title":"Menopause."},{"key":"7552_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/GME.0000000000000955","volume":"25","author":"VL Cruz","year":"2018","unstructured":"Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS, Wajsfeld T, Fernandes CE (2018) Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 25:21\u201328. https:\/\/doi.org\/10.1097\/GME.0000000000000955","journal-title":"Menopause"},{"key":"7552_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/lsm.22569","volume":"49","author":"A Gaspar","year":"2017","unstructured":"Gaspar A, Brandi H, Gomez V, Luque D (2017) Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 49:160\u2013168. https:\/\/doi.org\/10.1002\/lsm.22569","journal-title":"Lasers Surg Med"},{"issue":"8","key":"7552_CR30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/GME.0000000000001333","volume":"26","author":"CA Politano","year":"2019","unstructured":"Politano CA, Costa-Paiva L, Aguiar LB, Machado HC, Baccaro LF (2019) Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial. Menopause 26(8):833\u2013840. https:\/\/doi.org\/10.1097\/GME.0000000000001333","journal-title":"Menopause"},{"key":"7552_CR31","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/medicina58060770","volume":"58","author":"V Benini","year":"2022","unstructured":"Benini V, Ruffolo AF, Casiraghi A, Degliuomini RS, Frigerio M, Braga A, Serati M, Torella M, Candiani M, Salvatore S (2022) New innovations for the treatment of vulvovaginal atrophy: an up-to-date review. Medicina (Kaunas) 58:770. https:\/\/doi.org\/10.3390\/medicina58060770","journal-title":"Medicina (Kaunas)"},{"key":"7552_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.maturitas.2017.01.012","volume":"99","author":"M Gambacciani","year":"2017","unstructured":"Gambacciani M, Palacios S (2017) Laser therapy for the restoration of vaginal function. Maturitas 99:10\u201315. https:\/\/doi.org\/10.1016\/j.maturitas.2017.01.012","journal-title":"Maturitas"},{"key":"7552_CR33","first-page":"523","volume":"67","author":"S Dinicola","year":"2015","unstructured":"Dinicola S, Pasta V, Costantino D, Guaraldi C, Bizzarri M (2015) Hyaluronic acid and vitamins are effective in reducing vaginal atrophy in women receiving radiotherapy. Minerva Ginecol 67:523\u2013531","journal-title":"Minerva Ginecol"},{"key":"7552_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.maturitas.2021.03.002","volume":"147","author":"F De Seta","year":"2021","unstructured":"De Seta F, Caruso S, Di Lorenzo G, Romano F, Mirandola M, Nappi RE (2021) Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: a double-blind randomized placebo-controlled study. Maturitas 147:34\u201340. https:\/\/doi.org\/10.1016\/j.maturitas.2021.03.002","journal-title":"Maturitas"},{"key":"7552_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/13697137.2020.1754386","volume":"23","author":"RE Nappi","year":"2020","unstructured":"Nappi RE, Kotek M, Bre\u0161t\u2019ansk\u00fd A, Giordan N, Tramentozzi E (2020) Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women. Climacteric 23:519\u2013524. https:\/\/doi.org\/10.1080\/13697137.2020.1754386","journal-title":"Climacteric"},{"key":"7552_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2022.08.013","volume":"167","author":"D Gold","year":"2023","unstructured":"Gold D, Nicolay L, Avian A, Greimel E, Balic M, Pristauz-Telsnigg G, Tamussino K, Trutnovsky G (2023) Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: a randomized controlled trial. Maturitas 167:1\u20137. https:\/\/doi.org\/10.1016\/j.maturitas.2022.08.013","journal-title":"Maturitas"},{"key":"7552_CR37","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/GME.0000000000001122","volume":"25","author":"B Hersant","year":"2018","unstructured":"Hersant B, SidAhmed-Mezi M, Belkacemi Y, Darmon F, Bastuji-Garin S, Werkoff G, Bosc R, Niddam J, Hermeziu O, La Padula S, Meningaud JP (2018) Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause 25:1124\u20131130. https:\/\/doi.org\/10.1097\/GME.0000000000001122","journal-title":"Menopause"},{"key":"7552_CR38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/13697137.2021.1898580","volume":"24","author":"G Buzzaccarini","year":"2021","unstructured":"Buzzaccarini G, Marin L, Noventa M, Vitagliano A, Riva A, Dessole F, Capobianco G, Bordin L, Andrisani A, Ambrosini G (2021) Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric 24:560\u2013571. https:\/\/doi.org\/10.1080\/13697137.2021.1898580","journal-title":"Climacteric"},{"key":"7552_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2020-3-2","volume":"9","author":"S Palacios","year":"2020","unstructured":"Palacios S (2020) Ospemifene for vulvar and vaginal atrophy: an overview. Drugs Context 9:1\u20135. https:\/\/doi.org\/10.7573\/dic.2020-3-2","journal-title":"Drugs Context"},{"key":"7552_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/13697137.2013.834493","volume":"17","author":"SR Goldstein","year":"2014","unstructured":"Goldstein SR, Bachmann GA, Koninckx PR, Lin VH, Portman DJ, Ylikorkala O, Ospemifene Study Group (2014) Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy. Climacteric 17:173\u2013182. https:\/\/doi.org\/10.3109\/13697137.2013.834493","journal-title":"Climacteric"},{"key":"7552_CR41","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.jsxm.2018.10.009","volume":"15","author":"S Alvisi","year":"2018","unstructured":"Alvisi S, Baldassarre M, Gava G, Mancini I, Gagliardi M, Seracchioli R, Meriggiola MC (2018) Structure of epithelial and stromal compartments of vulvar and vaginal tissue from women with vulvo-vaginal atrophy taking ospemifene. J Sex Med 15:1776\u20131784. https:\/\/doi.org\/10.1016\/j.jsxm.2018.10.009","journal-title":"J Sex Med"},{"key":"7552_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3109\/13697137.2014.954996","volume":"18","author":"G Constantine","year":"2015","unstructured":"Constantine G, Graham S, Portman DJ, Rosen RC, Kingsberg SA (2015) Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial. Climacteric 18:226\u2013232. https:\/\/doi.org\/10.3109\/13697137.2014.954996","journal-title":"Climacteric"},{"issue":"8","key":"7552_CR43","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1080\/09513590.2018.1441398","volume":"34","author":"MC Schiavi","year":"2018","unstructured":"Schiavi MC, Sciuga V, Giannini A, Vena F, D\u2019oria O, Prata G, Di Tucci C, Savone D, Aleksa N, Capone C, Di Mascio D, Meggiorini ML, Monti M, Zullo MA, Muzii L, Benedetti Panici P (2018) Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality? Gynecol Endocrinol. 34(8):666\u2013669. https:\/\/doi.org\/10.1080\/09513590.2018.1441398","journal-title":"Gynecol Endocrinol."},{"issue":"3","key":"7552_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ygyno.2017.01.004","volume":"144","author":"J Seror","year":"2017","unstructured":"Seror J, Roulot A, Guillot E, Rouzier R (2017) Colpoplasty by laparoscopic modified Davydov\u2019s procedure. Gynecol Oncol 144(3):647\u2013648. https:\/\/doi.org\/10.1016\/j.ygyno.2017.01.004","journal-title":"Gynecol Oncol"},{"key":"7552_CR45","first-page":"35","volume":"16","author":"SN Davydov","year":"1974","unstructured":"Davydov SN, Zhvitiashvili OD (1974) Formation of vagina (colpopoiesis) from peritoneum of Douglas pouch. Acta Chir Plast 16:35\u201341","journal-title":"Acta Chir Plast"},{"key":"7552_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.brachy.2023.01.005","volume":"22","author":"BA Quinn","year":"2023","unstructured":"Quinn BA, Deng X, Sullivan SA, Carter J, Bandyopadhyay D, Fields EC (2023) Change in vaginal length and sexual function in women who undergo surgery \u00b1 radiation therapy for endometrial cancer. Brachytherapy 22:334\u2013342. https:\/\/doi.org\/10.1016\/j.brachy.2023.01.005","journal-title":"Brachytherapy"},{"key":"7552_CR47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","volume":"82","author":"AY Bahng","year":"2012","unstructured":"Bahng AY, Dagan A, Bruner DW, Lin LL (2012) Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 82:667\u2013673. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.10.071","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7552_CR48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ijrobp.2012.01.064","volume":"84","author":"V Gondi","year":"2012","unstructured":"Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, Straub M, Bradley KA (2012) Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis. Int J Radiat Oncol Biol Phys 84:973\u2013982. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.064","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7552_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2015.06.018","volume":"116","author":"E Law","year":"2015","unstructured":"Law E, Kelvin JF, Thom B, Riedel E, Tom A, Carter J, Alektiar KM, Goodman KA (2015) Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol 116:149\u2013155. https:\/\/doi.org\/10.1016\/j.radonc.2015.06.018","journal-title":"Radiother Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07552-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T10:14:46Z","timestamp":1721297686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07552-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["7552"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07552-9","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"18 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics committee approval is not required to carry out systematic review research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable for systematic review manuscripts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable for systematic review manuscripts.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}